Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis
US6498152B1 · kind B1 · utility
2Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2000 |
| Grant date | Dec 24, 2002 |
| Priority date | — |
| Expiry date | Dec 21, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the prevention of restenosis of vascular passages following surgical removal of obstructions, by means of local administration of farnesyl transferase inhibitors to the vascular wall. This allows effective use of particularly low dosages with minimal side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.